Literature DB >> 6187687

Delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice is enhanced by dextran sulfate.

M Kishima, C Kuniyasu, M Nakagawa.   

Abstract

The enhancing effect of dextran sulfate (DS) on delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice was evaluated by means of delayed footpad swelling. Mice pretreated subcutaneously with nonviable M. pulmonis and DS had significantly increased delayed footpad swelling when the mice were injected subcutaneously in the footpad with the same antigen 7 days later. Delayed footpad swelling was not detected in mice pretreated only with nonviable M. pulmonis or DS followed by footpad injection with nonviable M. pulmonis. Subcutaneous pretreatment in the scruff of the neck with nonviable M. pulmonis and DS was more effective in eliciting delayed footpad swelling than intravenous or intraperitoneal pretreatment. Delayed footpad swelling did not develop when mice were injected in the footpad with nonviable Mycoplasma hyopneumoniae, M. gallisepticum, M. dispar, or M. bovis on day 7 after pretreatment with M. pulmonis and DS. Injection of nonviable M. pulmonis in the footpad on day 3 after pretreatment with M. pulmonis and DS resulted in no significant footpad swelling, but injection in the footpad on days 7, 14, 21, and 28 resulted in significant footpad swelling. Delayed footpad swelling was transferred by intravenous injection with spleen cells of mice which were pretreated with nonviable M. pulmonis and DS into nontreated recipient mice. Intravenous injection with anti-mouse thymus cell rabbit serum into the mice which were previously pretreated with nonviable M. pulmonis and DS reduced the delayed footpad swelling significantly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187687      PMCID: PMC348023          DOI: 10.1128/iai.39.2.823-829.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Skin-sensitivity reactions in calves inoculated with Mycoplasma bovis antigens: humoral and cell-mediated responses.

Authors:  R H Bennett; E J Carroll; D E Jasper
Journal:  Am J Vet Res       Date:  1977-11       Impact factor: 1.156

2.  The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.

Authors:  F W Denny; D Taylor-Robinson; A C Allison
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

3.  Cell-mediated immune response following Mycoplasma pneumoniae infection in man. II. Leucocyte migration inhibition.

Authors:  G Biberfeld
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

4.  Effect of stimulation and blockade of mononuclear phagocyte system on the delayed footpad reaction to SRBC in mice.

Authors:  Y Yoshikai; S Miake; T Matsumoto; K Nomoto; K Takeya
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

5.  Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic myeoplasmal membranes.

Authors:  Y Naot; S Davidson; E S Lindenbaum
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

6.  Simultaneous stimulation and suppression of two different indicators of the cell-mediated immune response by the immunoregulator dextran sulphate.

Authors:  R E McCarthy; G F Babcock
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

7.  Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract.

Authors:  J R Lindsey; H Cassell
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307

8.  Enhancement of weak mixed lymphocyte-type reactions by hydrophilic polymers.

Authors:  S A Ben-Sasson; P A Henkart
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Pneumonia due to mycoplasma in gnotobiotic mice. I. Pathogenicity of Mycoplasma pneumoniae, Mycoplasma salivarium, and Mycoplasma pulmonis for the lungs of conventional and gnotobiotic mice.

Authors:  I I Lutsky; A B Organick
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

10.  Lymphocyte activation by various Mycoplasma strains and species.

Authors:  Y Naot; J G Tully; H Ginsburg
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.